SYNTARA LIMITED - News & Media

1.96%

2.5¢

Market Cap $40.80M

Healthcare Biotechnology

Syntara Limited is an Australia-based clinical-stage drug development company. The... Syntara Limited is an Australia-based clinical-stage drug development company. The Company is targeting extracellular matrix dysfunction with its amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The Company’s lead candidate SNT-5505 is for the bone marrow cancer myelofibrosis which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its product candidate, SNT-4728, is an inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis and cardiac fibrosis.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. LATEST: Race Oncology Accelerates Game-Changing Cancer Drug.

Articles & Videos

Clinical trial data for MF candidate proves promising for Syntara

Syntara Ltd has reported positive interim results from its Phase 2 trial to test the efficacy and safety of SNT-5505

10 Dec 2024 16:08 (AEDT)

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.5¢		Change -0.001(1.96%)		Mkt cap ! $40.80M

Open	High	Low	Value	Volume
2.5¢	2.5¢	2.4¢	$147.7K	5.911M

Buyers (Bids)

No.	Vol.	Price($)
17	1626571	2.4¢

Sellers (Offers)

Price($)	Vol.	No.
2.5¢	311363	2

View Market Depth

No.	Vol.	Price($)
16	1476571	0.024
8	1601649	0.023
2	244000	0.022
2	85000	0.021
9	699545	0.020

Price($)	Vol.	No.
0.025	311363	2
0.026	5040723	8
0.027	2090235	7
0.028	1256484	5
0.029	1158966	7

Last trade - 16.10pm 05/09/2025 (20 minute delay)

SNT (ASX) Chart

SYNTARA LIMITED - News & Media

Articles & Videos

Clinical trial data for MF candidate proves promising for Syntara

Buyers (Bids)

Sellers (Offers)

Top Stories